These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 14567520)

  • 21. Common adverse events associated with the use of ribavirin for severe acute respiratory syndrome in Canada.
    Knowles SR; Phillips EJ; Dresser L; Matukas L
    Clin Infect Dis; 2003 Oct; 37(8):1139-42. PubMed ID: 14523782
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prolonged disturbances of in vitro cytokine production in patients with severe acute respiratory syndrome (SARS) treated with ribavirin and steroids.
    Jones BM; Ma ES; Peiris JS; Wong PC; Ho JC; Lam B; Lai KN; Tsang KW
    Clin Exp Immunol; 2004 Mar; 135(3):467-73. PubMed ID: 15008980
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacologic treatment of SARS: current knowledge and recommendations.
    Tai DY
    Ann Acad Med Singap; 2007 Jun; 36(6):438-43. PubMed ID: 17597972
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adverse events associated with high-dose ribavirin: evidence from the Toronto outbreak of severe acute respiratory syndrome.
    Muller MP; Dresser L; Raboud J; McGeer A; Rea E; Richardson SE; Mazzulli T; Loeb M; Louie M;
    Pharmacotherapy; 2007 Apr; 27(4):494-503. PubMed ID: 17381375
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Temporal relationship of viral load, ribavirin, interleukin (IL)-6, IL-8, and clinical progression in patients with severe acute respiratory syndrome.
    Wang WK; Chen SY; Liu IJ; Kao CL; Chen HL; Chiang BL; Wang JT; Sheng WH; Hsueh PR; Yang CF; Yang PC; Chang SC;
    Clin Infect Dis; 2004 Oct; 39(7):1071-5. PubMed ID: 15472864
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early defervescence and SARS recovery.
    Wang JT; Wang JL; Fang CT; Chang SC
    Emerg Infect Dis; 2004 Mar; 10(3):544-5. PubMed ID: 15116707
    [No Abstract]   [Full Text] [Related]  

  • 27. A young infant with severe acute respiratory syndrome.
    Sit SC; Yau EK; Lam YY; Ng DK; Fong NC; Hui YW; Cheng WF; Leung CW; Chiu MC
    Pediatrics; 2003 Oct; 112(4):e257. PubMed ID: 14523208
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Present state of in vitro and in vivo studies on efficacy of medical nonspecific protective agents with respect to genotype IV coronavirus causing severe acute respiratory syndrome].
    Shchukina VN; Loginova SIa; Borisevich SV; Bondarev VP
    Antibiot Khimioter; 2011; 56(9-10):41-6. PubMed ID: 22586904
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Outcome of coronavirus-associated severe acute respiratory syndrome using a standard treatment protocol.
    Lau AC; So LK; Miu FP; Yung RW; Poon E; Cheung TM; Yam LY
    Respirology; 2004 Jun; 9(2):173-83. PubMed ID: 15182266
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Severe Acute Respiratory Syndrome and pregnancy.
    Wong SF; Chow KM; de Swiet M
    BJOG; 2003 Jul; 110(7):641-2. PubMed ID: 12842052
    [No Abstract]   [Full Text] [Related]  

  • 31. SARS: pharmacotherapy.
    Tsang K; Zhong NS
    Respirology; 2003 Nov; 8 Suppl():S25-30. PubMed ID: 15018130
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The severe acute respiratory syndrome].
    Madariaga MG; Gotuzzo E
    Rev Clin Esp; 2004 Jun; 204(6):323-5. PubMed ID: 15171896
    [No Abstract]   [Full Text] [Related]  

  • 33. Critics slam treatment for SARS as ineffective and perhaps dangerous.
    Cyranoski D
    Nature; 2003 May; 423(6935):4. PubMed ID: 12721587
    [No Abstract]   [Full Text] [Related]  

  • 34. [Pathogenesis, physiopathology, clinical manifestations and treatment of Hantavirus pulmonary syndrome].
    Seijó AC
    Medicina (B Aires); 1998; 58 Suppl 1():19-24. PubMed ID: 9674241
    [No Abstract]   [Full Text] [Related]  

  • 35. Old drugs for a new bug: influenza, HIV drugs enlisted to fight SARS.
    Vastag B
    JAMA; 2003 Oct; 290(13):1695-6. PubMed ID: 14519691
    [No Abstract]   [Full Text] [Related]  

  • 36. Photolabeling probes of ribavirin and EICAR.
    Wu Q; Qu F; Wan J; Xia Y; Peng L
    Nucleosides Nucleotides Nucleic Acids; 2005; 24(5-7):999-1008. PubMed ID: 16248080
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Potential for receptor-based antiviral drugs against SARS.
    Williams RK; Yeager CL; Holmes KV
    Lancet; 2003 Jul; 362(9377):77. PubMed ID: 12853208
    [No Abstract]   [Full Text] [Related]  

  • 38. SARS treatment: who will lead the way forward?
    Larkin M
    Lancet Infect Dis; 2003 Jul; 3(7):400. PubMed ID: 12837339
    [No Abstract]   [Full Text] [Related]  

  • 39. Advances in clinical diagnosis and treatment of severe acute respiratory syndrome.
    Nie QH; Luo XD; Hui WL
    World J Gastroenterol; 2003 Jun; 9(6):1139-43. PubMed ID: 12800213
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Potential for antiviral treatment of severe acute respiratory syndrome.
    Davidson A; Siddell S
    Curr Opin Infect Dis; 2003 Dec; 16(6):565-71. PubMed ID: 14624107
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.